EGF and neoplasm: The tumor-suppressing properties of MIR503HG were linked with (i) increased expression of mesenchymal markers and decreased expression of epithelial markers and (ii) decreased expression of the transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1).